Company: BSX
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0000885725-25-000050
Chunk: 39

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 1
Chunk 39
---
.5 1,487.4 1,494.0 1,484.5 

Refer to notes to the unaudited consolidated financial statements. Amounts may not add due to rounding.

3

Table of Contents

BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) 

Three Months EndedSeptember 30,Nine Months EndedSeptember 30,(in millions)2025202420252024Net income (loss)$755 $468 $2,222 $1,284 Other comprehensive income (loss), net of tax:Foreign currency translation adjustment(28)(181)(719)(79)Net change in derivative financial instruments62 (100)(238)(95)Net change in defined benefit pensions and other items(0)(0)(1)0 Other comprehensive income (loss)34 (282)(957)(173)Comprehensive income (loss)$789 $187 $1,265 $1,110 Net income (loss) attributable to noncontrolling interests(0)(0)(4)(4)Other comprehensive income (loss) attributable to noncontrolling interests1 10 7 4 Comprehensive income (loss) attributable to noncontrolling interests1 10 3 0 Comprehensive income attributable to Boston Scientific common stockholders$788 $177 $1,262 $1,110 

Refer to notes to the unaudited consolidated financial statements. Amounts may not add due to rounding.

4

Table of Contents

BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

 As of(in millions, except share and per share data)September 30, 2025December 31, 2024ASSETS  Current assets:  Cash and cash equivalents$1,275 $414 Trade accounts receivable, net2,828 2,558 Inventories2,921 2,810 Prepaid income taxes310 307 Other current assets701 831 Total current assets8,035 6,920 Property, plant and equipment, net3,795 3,294 Goodwill18,214 17,089 Other intangible assets, net7,162 6,684 Deferred tax assets3,669 3,655 Other long-term